Will Martin Marietta's $13.5B Lhoist Deal Strengthen Long-Term Growth?

MLM’s Lhoist Deal Expands Its Limestone Platform

Martin Marietta agreed on June 27 to combine with Lhoist North America in a transaction valued at approximately $13.5 billion. The consideration includes $7 billion in cash and $6.5 billion in stock, subject to customary adjustments.

Lhoist North America operates 20 quarries and production facilities and 45 distribution terminals. It also brings more than 2 billion tons of limestone reserves, adding long-lived mineral assets to Martin Marietta’s aggregates-led portfolio and expanding its upstream Specialties platform.

Martin Marietta Sees a Bigger Earnings Base After Lhoist

On a 2026 pro forma basis, including run-rate synergies and New Frontier Materials, the combined business is indicated to generate about $3.3 billion of adjusted EBITDA from continuing operations compared with roughly $2.4 billion for Martin Marietta standalone. The indicated adjusted EBITDA margin rises to 36% from 33%.

Free-cash-flow conversion is indicated at 81% for the combined company compared with 76% standalone. That improvement is central to the strategic case because stronger cash conversion would help support deleveraging after closing while giving Martin Marietta more flexibility to reinvest across its expanded portfolio.

MLM’s Lhoist Exposure Broadens End-Market Reach

The transaction would broaden Martin Marietta’s exposure to industrial, infrastructure, manufacturing and environmental applications. Lhoist North America’s lime products serve markets including steel production, soil stabilization and water treatment, complementing Martin Marietta’s construction aggregates business.

The deal also fits a broader aggregates-led consolidation theme. Vulcan Materials Company VMC, the nation’s largest producer of construction aggregates, remains centered on aggregates. CRH plc CRH agreed in June to acquire Arcosa for about $8.5 billion, reinforcing its own U.S. aggregates platform and infrastructure exposure.

Martin Marietta Must Absorb Financing and Execution Risk

The cash component will increase the importance of balance-sheet management. Martin Marietta ended June with $112 million of unrestricted cash and $742 million of unused borrowing capacity, and it later secured a commitment for a new three-year, $1.5 billion senior unsecured term loan facility tied to the Lhoist transaction.

Management expects pro forma net leverage of about 3.7 times at closing and has stated a goal of reducing it below 2.5 times within 24 months. Risks include obtaining financing and regulatory approvals, integrating the businesses, realizing expected synergies and managing dilution from newly issued shares. The company’s existing 2026 adjusted EBITDA guidance of $2.36-$2.50 billion excludes Lhoist contributions.

MLM’s Mixed Style Scores Temper the Lhoist Upside

The Lhoist transaction could strengthen Martin Marietta’s long-term earnings mix if the company realizes the expected synergies, cash conversion and end-market diversification. The near-term investment case is less straightforward because the deal introduces leverage and integration demands before those benefits are proven.

MLM currently carries a Zacks Rank #3 (Hold), a neutral near-term signal based on earnings estimate revisions. It has a Value Score of D, Growth Score of F, Momentum Score of F and VGM Score of F. Because the Zacks Style Scores are designed to complement the Zacks Rank, those weaker grades argue for balancing the transaction’s long-term potential against execution and valuation considerations rather than treating the deal as an automatic positive. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research